Showing results (1731-1740 of 1,831) with videos related to

Sort By:
Pageof 184
Frontiers in Oncology|May 9, 2025
Corrigendum: Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response earlyMariangela Morelli, Francesca Lessi, Serena Barachini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2022
Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO studyLucas Guillo, Benoit Flachaire, Jérôme Avouac, et al.
Journal of the National Cancer Institute|October 15, 2025
Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancerDaniela Ottaviani, Mihaela Ola, Alessandra Allotta, et al.
Frontiers in Oncology|September 22, 2022
Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response earlyMariangela Morelli, Francesca Lessi, Serena Barachini, et al.
Journal of Medicinal Chemistry|June 13, 2020
Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) InhibitorsYongfu Liu, Jun Wu, Mingwei Zhou, et al.
Eclinicalmedicine|June 27, 2024
Guidance on mucositis assessment from the MASCC Mucositis Study Group and ISOO: an international Delphi studyRagda Abdalla-Aslan, Pierluigi Bonomo, Dorothy Keefe, et al.
Journal of Hematology & Oncology|November 7, 2015
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemiaIlaria Iacobucci, Andrea Ghelli Luserna Di Rorà, Maria Vittoria Verga Falzacappa, et al.
Cancer Medicine|March 31, 2023
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical studyGiovanni Marconi, Anna Candoni, Roberta Di Nicola, et al.
Human Molecular Genetics|March 4, 2025
A novel recurrent ARL3 variant c.209G > A p.(Gly70Glu) causes variable non-syndromic dominant retinal dystrophy with defective lipidated protein transport in human retinal stem cell modelsJulio C Corral-Serrano, Veronika Vaclavik, Stijn Van de Sompele, et al.
Dementia & Neuropsychologia|August 28, 2024
Adaptation, testing, and use of the "iSupport for Dementia" program in different countries: a systematic reviewLarissa Corrêa, Aline Cristina Martins Gratão, Déborah Oliveira, et al.
Pageof 184